A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models - Université de Lille Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2023

A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

Résumé

In patients with type 2 diabetes, pancreatic beta cells progressively degenerate and gradually lose their ability to produce insulin and regulate blood glucose. Beta cell dysfunction and loss is associated with an accumulation of aggregated forms of islet amyloid polypeptide (IAPP) consisting of soluble prefibrillar IAPP oligomers as well as insoluble IAPP fibrils in pancreatic islets. Here, we describe a human monoclonal antibody selectively targeting IAPP oligomers and neutralizing IAPP aggregate toxicity by preventing membrane disruption and apoptosis in vitro. Antibody treatment in male rats and mice transgenic for human IAPP, and human islet-engrafted mouse models of type 2 diabetes triggers clearance of IAPP oligomers resulting in beta cell protection and improved glucose control. These results provide new evidence for the pathological role of IAPP oligomers and suggest that antibody-mediated removal of IAPP oligomers could be a pharmaceutical strategy to support beta cell function in type 2 diabetes.
Fichier principal
Vignette du fichier
A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models.pdf (3.67 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04558243 , version 1 (24-04-2024)

Licence

Identifiants

Citer

Fabian Wirth, Fabrice D. Heitz, Christine Seeger, Ioana Combaluzier, Karin Breu, et al.. A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models. Nature Communications, 2023, Nature Communications, 14, pp.6294. ⟨10.1038/s41467-023-41986-0⟩. ⟨hal-04558243⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More